Nishra H. Shah on Muck Rack

Nishra H. Shah

As seen in: Taylor & Francis Online
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nishra H.

Contact Nishra H., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Sacituzumab Govitecan in HER2-Negative Breast Cancer: Redefining Treatment Paradigms

|
By Avinash Khadela, Kashvy R. Morakhia, Nishra H. Shah, Vibha G. Kanjani
| Taylor & Francis Online
Abstract Human epidermal growth factor 2-negative breast cancer (HER2-BC) is characterized by the lack of HER2 amplification and encompasses triple-negative breast cancer and hormone receptor-positive HER2-negative breast cancer. Triple-negative breast cancer is distinguished by a total lack of estrogen and progesterone receptors, along with the lack of HER2 amplification.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified